Observational Study Investigating the Prescription of Lipid-Lowering Drugs for Primary and/or Secondary Prevention in Residents Aged 80 Years and Over Institutionalized in Nursing Homes in Brest.
To evaluate the prescription of lipid-lowering therapy in nursing home residents aged 80 and older. Observational descriptive study, led in Brest, France, between February and May 2017. 15 nursing homes in Brest, France. Nursing home residents, aged 80 and older, treated with a lipid-lowering therapy for primary and / or secondary prevention. The primary endpoint was to observe the frequency of prescription of lipid-lowering therapy at the time of the study. The secondary endpoints were to analyse the relevance of these prescriptions regarding the latest French recommendations and current literature data and to evaluate the monitoring of treatment. 213 of the 1121 included residents (19%) were treated with a lipid-lowering drugs. A total of 141 prescriptions (66.2%) were considered irrelevant. In the past 12 months, monitoring of lipids, liver and muscle enzymes was observed respectively in 41.3%, 60.1% and 9.4% of residents. lipid-lowering prescription was not optimal in nursing homes. The results highlighted inadequate treatment monitoring and a gap between the French National Authority for Health (HAS) recommendations and actual practice.